Costello syndrome is a rare, autosomal-dominant syndrome caused by activating missense mutations in the Harvey rat sarcoma viral oncogene homolog (HRAS), most often p.G12S. Several rare mutations have consistently been associated with a more severe phenotype that is often lethal in infancy. Cause of death is most often respiratory failure, with hypertrophic cardiomyopathy playing a significant role in morbidity. Impaired fibroblast elastogenesis is thought to contribute to the Costello phenotype, but reports of histologic evidence of disordered elastogenesis at autopsy are limited. We report a patient with Costello syndrome due to a rare tandem base substitution (c.35_36GC.AA) resulting in the p.G12E missense change. The proband died at the age of 3 months from respiratory failure, with minimal evidence of cardiomyopathy. The autopsy disclosed pulmonary vascular dysplasia affecting small arteries and veins associated with abnormal elastin distribution in tortuous dilated arteries and veins, with nonuniform wall thickness and semiobstructive lesions at artery branch points typical of early pulmonary hypertensive vascular disease. Elastic fibers in the dermis were abnormally short and fragmented. This case suggests that disordered elastogenesis in the pulmonary vasculature and undiagnosed (or underdiagnosed) pulmonary hypertension may contribute to morbidity in patients with Costello syndrome.
INTRODUCTION
Costello syndrome is a rare autosomal-dominant disorder caused by activating mutations in the Harvey rat sarcoma viral oncogene homolog (HRAS) [1, 2] . Characteristics of Costello syndrome include coarse craniofacial features, short stature, poor feeding and growth, cardiovascular anomalies, developmental delay/intellectual disability, loose/extensible skin and joints, laryngomalacia, and increased risk for solid tumors. The most commonly reported HRAS mutations in Costello syndrome are p.G12S followed by p.G12A [3] . Several rare mutations have consistently been associated with a more severe phenotype that is often lethal in infancy, for example, p.G12D, p.G12C, and p.G12E [2, 4, 5] (see Table 1 for summary). Cause of death in neonatal lethal cases is most often respiratory failure, with hypertrophic cardiomyopathy playing a significant factor in morbidity. Persistent pulmonary hypertension is described in one infant [6] . Fibroblasts in Costello syndrome have an increased rate of proliferation and impaired elastogenesis, which are thought to contribute to the phenotype [7] . Reports of disordered elastogenesis at autopsy in patients with Costello syndrome provide limited histologic support.
We describe a patient with Costello syndrome caused by the rare p.G12E mutation who died at the age of 
METHODS
We report detailed clinical, genetic, and pathologic findings in an infant with Costello syndrome caused by a rare mutation. Written permission from the infant's parents was obtained prior to publication.
RESULTS

Clinical and phenotypic report
The female patient was the 2nd child born to healthy, nonconsanguineous parents of European-American ancestry. Maternal age was 35 years and paternal age was 34 years. The pregnancy was complicated by gestational diabetes diagnosed at 32 weeks, polyhydramnios, and concern for multiple fetal anomalies, including macrocephaly, ventriculomegaly, short long bones, and possible coarctation of the aorta. The patient was delivered by Csection at 37 weeks as a result of fetal heart rate decelerations. She required positive pressure ventilation and continuous positive airway pressure (CPAP) in the delivery room for low heart rate and poor color. Apgar scores were 6 and 8. Birth weight was 3350 g (45th centile), length 47 cm (16th centile), and head circumference 36 cm (75th centile). The infant was hyperteloric, with downslanting palpebral fissures, flat nasal bridge, and upturned nasal tip (Fig. 1A) . She had a short neck with excess nuchal skin. Her ears were low-set and posteriorly rotated, with overfolded helices. She had a wide space between her 1st and 2nd toes bilaterally and excess skin on her hands and feet, with deep palmar and plantar creases (Fig. 1B) . Limbs appeared to have mild rhizomelic shortening. Because of hypotonia and retractions, the infant required intubation, which was difficult because of poor glottis exposure. The initial echocardiogram demonstrated mild biventricular hypertrophy, moderate patent ductus arteriosus with bidirectional shunting, and small patent foramen ovale with left to right shunting.
The patient was hospitalized for 5 consecutive weeks after her birth. She briefly required treatment for hypoglycemia. She failed extubation on day-of-life (DOL) 3, demonstrating excessive secretions with increased work of breathing. Upper gastrointestinal series and water-soluble enema were performed on DOL 5 as a result of emesis and feeding intolerance. Imaging findings suggested atypical duodenal malrotation but no obstruction. Microlaryngoscopy and bronchoscopy performed on DOL 6 demonstrated pharyngomalacia, subglottic edema, and ulceration. Echocardiogram on DOL 9 showed septal flattening and right ventricular dysfunction, and she was started on inhaled nitric oxide and milrinone to treat pulmonary hypertension. She was successfully extubated on DOL 10 to CPAP, gradually weaned off support to room air by DOL 50, and transitioned to sildenafil by DOL 16. Evidence for pulmonary hypertension gradually declined. Atrial premature beats on DOL 9 initially improved, but on DOL 34 she developed sustained atrial tachycardia for several hours. This was controlled with digoxin and flecainide. On DOL 34 there was also concern for clinical seizures, but prolonged electroencephalogram was inconclusive. Brain magnetic resonance imaging on DOL 34 demonstrated mild prominence and asymmetry of the lateral ventricles, with the left larger than the right. Ophthalmologic exam demonstrated a very small polar cataract in each eye. Poor feeding persisted, and a gastrostomy tube was placed on DOL 38. A Ladd's procedure corrected malrotation. Endoscopic evaluation of swallowing on DOL 34 showed moderate laryngomalacia, increased secretions with decreased swallowing, and laryngeal penetration without frank aspiration. She was discharged on DOL 53 feeding entirely by G-tube and with no respiratory support. Medications included flecainide, digoxin, and sildenafil.
A polysomnogram (PSG) was performed at 87 days of age because of snoring and respiratory pauses during sleep. During 310 minutes of sleep there were 133 obstructive apneas and 54 obstructive hypopneas, for an obstructive index of 36.8. The minimum oxygen saturation associated with the obstructive events was 84.7%. The overall impression was severe obstructive sleep apnea with mild-moderate degree of oxygen desaturation. Oxygen therapy at J L/minute decreased the frequency of respiratory events and improved oxygenation. The patient was readmitted to the hospital on DOL 99 because of diaphoresis, prolonged episodes of atrial tachycardia, and respiratory distress. An echocardiogram performed on DOL 100 demonstrated mild left ventricular hypertrophy, no outflow tract obstruction, and qualitatively normal systolic function (ejection fraction 55-60%). Atrial tachycardia was controlled with intravenous amiodarone, and she was transitioned to flecainide and propranolol. She did not tolerate weaning of respiratory support and required either CPAP or high-flow nasal cannula. Bronchoscopy demonstrated multiple levels of airway obstruction, including pharyngomalacia, glossoptosis, and laryngomalacia. After supraglottoplasty respiratory support was weaned to 1 L/min by nasal cannula. However, episodic worsening of respiratory status continued, and she died on DOL 123 from respiratory failure.
Autopsy findings
Postmortem examination demonstrated borderline low body length (55 cm; expected, 59 cm; 50th centile for individuals with Costello syndrome [8] ). Craniofacial and other body characteristics were as described above. The heart weight of 34.8 g was mildly enlarged for body length (normal, 25 g). The brain weight of 587 g was slightly heavier than expected (normal, 489 g), which may be explained by edema. There were no structural abnormalities identified in the brain. Overall, there was mild growth delay compared with expected for a normal 4-month-old infant girl using autopsy charts [9] .
Although clinical imaging and mildly increased cardiac weight suggested ventricular overload, there was no myocyte hypertrophy or myofiber disarray. No systemic vasculopathy was identified in a conventional organ sample at autopsy. Elastic staining of skin demonstrated markedly decreased elastic fibers that were thin and fragmented compared to the age-matched control (Fig. 2) . Pentachrome stain, performed to assess presence of glycosaminoglycans, demonstrated increased bluish amorphous deposition of glycosaminoglycans in the dermis, compared to normal.
Multifocal pulmonary vascular abnormalities involved the intrapulmonary pulmonary veins and arteries (Figs. 3-5 ). Elastic staining of pulmonary arteries and veins demonstrated disorganized, nonuniform elastic fiber composition as well as foci of both deficiency and excess of medial smooth muscle, particularly in medium-sized arteries. Many tortuous intrapulmonary veins had asymmetric musculoelastic wall thickening. The alignment of the pulmonary veins was normal. The walls of the pulmonary hilar arteries and veins were not systematically sampled but seemed normal. Arteries that accompanied cartilage-bearing bronchi were tortuous and irregularly dilated or hypertrophied, often abruptly transitioning from thick-to thin-walled at or near branch points (Fig. 6) . Depending on the orientation of the section, branch point stenosis and poststenotic local dilation were often seen. Rare bulky deposits of myxoid acid glycosaminoglycans obstructed small pulmonary arteries. Thrombosis was extremely rare; the only example in 6 large samples of paraffin-embedded lung was located in an exaggerated branch point cushion. There was no vasculitis. The pulmonary vascular changes at arterial branch points resembled those reported in early primary and secondary pulmonary hypertension, but typical features of hypertensive vasculopathy, such as uniform muscularization of the small pulmonary arteries, intimal fibrosis, and muscularization of the pulmonary arterioles, were absent [10, 11] . Elastic fibers in the bronchi were fine, short, and disorganized compared to the bronchus of an age-and size-matched control bronchus (Fig. 7) .
Genetic studies
Routine chromosomes and single nucleotide polymorphism (SNP) microarray showed normal results. Noonanspectrum testing sent to a CLIA-certified lab reported a heterozygous c.35_36delinsAA mutation in exon 2 of HRAS, which is predicted to result in p.Gly12Glu (G12E). Using an allele-specific amplification protocol that took advantage of informative SNP rs41258054 (c.111+15G. A), follow-up laboratory studies demonstrated the de novo HRAS mutation results from tandem nucleotide base substitutions of paternal origin (Fig. 8) . Additionally, a novel heterozygous c.368G.A (p.Arg123Lys) variant of uncertain significance was identified in NRAS. The variant has not been reported previously either in individuals with clinical features of a Noonan-spectrum disorder or in large population studies. Both parents were subsequently tested, and the NRAS variant was found to be maternally inherited and therefore likely benign, given the normal phenotype of the patient's mother.
DISCUSSION
We report a patient with early lethal Costello syndrome caused by a rare HRAS mutation predicting G12E. This mutation has been reported previously only once, in an infant who died at 6 months of age [2] . That infant also had a particularly severe phenotype, including a severe cardiomyopathy, persistent hypoglycemia attributed to hyperinsulinemia, and hyperplasia of the Langerhans islets. The patient we report had mild cardiomegaly and transient hypoglycemia but no lesion of the islets at autopsy.
Two infants with early lethal Costello syndrome caused by G12D and G12C mutations both had severe hypertrophic cardiomyopathy [5] . Moreover, the mutation G12V has been established as a consistent cause of early lethal Costello syndrome with cardiomyopathy [12] . Our patient is unique in that severe cardiomyopathy was not detected by echocardiogram. Although the heart was slightly heavy for body length, the myocardium was normal by microscopy. Her death was due to respiratory failure, which was likely a combination of multilevel airway obstruction in addition to pulmonary hypertension, to which vascular dysplasia contributed.
Pulmonary vascular dysplasia associated with abnormal elastin morphology has not previously been described in Costello syndrome. Previous studies with qualitative and quantitative histological analyses showed impairment in elastin deposition in the skin, tongue, pharynx, larynx, alveoli, aorta, or coronary arteries of patients with Costello syndrome [13, 14] . In these tissues elastic fibers appeared fine, disrupted, and loosely constructed. Although multiple previous reports have established that fibroblasts from patients with Costello syndrome display disordered elastogenesis, abnormal elastin architecture has not been previ- ously identified in the pulmonary vasculature [7] . We suspect that the pulmonary vascular dysplasia contributed to the initial echocardiographic findings of pulmonary hypertension. Furthermore, distinctive semiobstructive arterial branch point lesions support the clinical impression of pulmonary hypertension. Cardiopulmonary reserve may have been further reduced by hypoxia due to obstructive apnea.
Primary disorders of elastogenesis, such as the genetically heterogeneous cutis laxa, provide insight into the complex process of elastin biogenesis. There are at least 10 distinct types of cutis laxa, including dominant, recessive, and X-linked forms, of which 9 have known genetic defects. The causative genes include those for elastin (ELN), fibulin 4 and 5 (FBLN4 and FBLN5), and latent transforming growth factor-beta (TGF-b) binding protein 4 (LTBP4). As a group, there is significant overlap with the Costello syndrome phenotype, including lax skin and joints, postnatal growth delay, developmental delay and intellectual disability, and hypotonia [15] . Arterial tortuosity has been reported as a feature of 4 cutis laxa types. Abnormal elastin in the extracellular matrix leads to increased TGF-b signaling in an attempt to upregulate the genes needed for production of elastic fibers [16] . Upregulation of TGF-b signaling is associated with widespread vasculopathy in Loeys-Dietz syndrome [17] . A child with an 11p duplication of HRAS was reported, and the HRAS duplication was speculated to cause the phenotype of severe cutis laxa and skin histology, demonstrating almost complete absence of elastin in the papillary dermis [18] . We hypothesize that the disordered elastogenesis in Costello syndrome is the result of activating HRAS mutations and may lead to upregulation of TGF-b signaling and resulting vasculopathy. This mechanism may be independent of or in addition to the increased deposition of glycosaminoglycan causing decreased elastin binding protein and resultant abnormal elastin deposition. Three previous reports have noted disordered lung development in infants with neonatal lethal Costello syndrome. Specifically, Burkitt-Wright and colleagues [12] noted congenital alveolar dysplasia in a patient with p.G12V who died around 1 month of age. Lo and colleagues [4] noted pulmonary lymphangiectasia and possible alveolar-capillary dysplasia in an infant with p.G12D who died at age 3 months as a result of respiratory failure. O'Shea and colleagues [6] reported persistent pulmonary hypertension in a newborn with Costello syndrome. In addition, severe lethal primary pulmonary hypertension is reported in Noonan syndrome, a related disorder [19] . Although our patient did not have evidence of pulmonary alveolar-capillary dysplasia, she had multifocal lymphangiectasia in the pleura and septa. This could be secondary to lymphatic obstruction by tortuous, asymmetrically thickened and dilated pulmonary veins, rather than a primary abnormality. This mechanism of secondary lymphangiectasia was recognized as one of 3 main groups of pulmonary lymphangiectasia by Noonan and colleagues in 1970 [20] . Disordered pulmonary vascular development in neonatal lethal Costello syndrome, lacking evidence for severe cardiomyopathy, suggests a significant role for pulmonary vascular abnormalities in the early mortality. Table 1 provides a summary of reported histopathologic findings in neonatal lethal Costello syndrome.
A small series suggested that airway obstruction is prevalent and may be of significant morbidity [21] . The authors recommended that Costello patients should be routinely assessed with PSG. The PSG findings in the patient reported here of severe obstructive sleep apnea support this recommendation, especially since disordered breathing, coupled with upper airway malacia, were significant factors in her death. This is the 1st reported patient with Costello syndrome and congenital cataracts. Ocular manifestations are associated with Noonan syndrome and cardiofaciocutaneous syndrome, with cataracts rarely reported [22] . Hashida and colleagues [23] reported local activation of MAPK signaling pathway in the lens of a patient with Noonan syndrome who had a mature cataract diagnosed in adulthood. A child with Noonan syndrome with a moderately dense asymmetric mixed nuclear and cortical cataract has been reported [22] . Although the mouse model of Costello syndrome (H-ras G12V ) does not develop cataracts, 80% of mice with activating Braf mutations (B-Raf +/LSLV600E ) develop cataracts by 32 weeks of age [24, 25] . Taken together, these findings suggest that cataract is a rare manifestation of RAS/ MAPK disorders.
In this patient, we demonstrated using allele-specific amplification that both base changes are on the same paternally inherited allele and result in a pG12E mutation of the protein. The identification of the G12E mutation as paternally derived is in keeping with previous reports that de novo Costello syndrome is more often caused by paternally derived mutations [26, 27] . It is thought that activating HRAS mutations in sperm are enriched through a process termed selfish spermatogonial selection and that this explains the preponderance of paternally derived mutations [28] . This patient's p.G12E mutation is likely caused by simultaneous substitution of the dinucleotide at c.35-36GC.AA in the paternal germline. Such tandem base substitutions (GC.TT/AA) are overrepresented in the germline, compared to blood or malignancies, and there are no reports of tandem base substitutions in HRAS in the Catalogue of Somatic Mutations in Cancer (COSMIC) [28] . Accordingly, the G12E mutation has not previously been reported as a somatic mutation in cancer. In contrast, the G12V mutation, which is associated with severe Costello syndrome and results from a single nucleotide substitution, is the most commonly reported somatic HRAS mutation associated with cancer (COSMIC database). The G12V mutation has been demonstrated to have the highest transformation potential of the HRAS mutations that cause Costello syndrome, and theoretically this may explain the more severe phenotype associated with germline G12V mutation, as well as its dominance of the reported HRAS somatic mutations in cancer [4, 29] . The transformation potential of G12E has not been measured quantitatively in vitro, although qualitative analysis suggests it has less potential than G12V and is similar to the common G12S mutation [30] . While this particular tandem substitution (and consequent G12E mutation) has been seen in only one patient previously [2] , based on its occurrence in sperm it may be more common in neonates than is currently appreciated. Identification of additional patients with HRAS p.G12E is required to determine if this mutation is always associated with a severe Costello phenotype.
CONCLUSION
In summary, we report a patient with neonatal lethal Costello syndrome caused by a rare HRAS tandem base substitution (c.35-36GC.AA), which results in a p.G12E change. This case is unique as a result of the minimal evidence for cardiomyopathy and the novel finding of generalized pulmonary vascular dysplasia with stigmata of pulmonary hypertensive vascular disease. Also, this is the 1st reported Costello syndrome patient with congenital cataracts. This case supports the notion that amino acid substitutions other than serine at the 12th position are associated with a particularly severe phenotype, but it challenges the notion that severe hypertrophic cardiomyopathy is the sole major contributor to morbidity. The identification of a 3rd case of Costello syndrome with disordered lung and respiratory tract function supports the inclusion of this finding as part of the phenotype. Finally, the finding of congenital cataracts, in conjunction with previous reports of cataracts in Noonan syndrome, supports the role of RAS/MAPK in cataract pathophysiology.
